John Clayton Taylor

Insider Reports History

Location
Durham, NC
Signature
/s/ John J. Kirby, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Clayton Taylor:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aceragen, Inc. CHIEF EXECUTIVE OFFICER, Director Common Stock 1,469,482 $749,436 $0.5100 17 Jan 2023 Direct
Aceragen, Inc. CHIEF EXECUTIVE OFFICER, Director Stock Options (Right to Buy) 74,500 20 Jan 2023 Direct
Aceragen, Inc. CHIEF EXECUTIVE OFFICER, Director Series Z Convertible Preferred Stock 0 17 Jan 2023 Direct

Insider Reports Filed by John Clayton Taylor

Symbol Company Period Transactions Value $ Form Type Role Filing Time
/report/000141588923001854-taylor-john-clayton-2023-01-20 Aceragen, Inc. 20 Jan 2023 1 $0 4 CHIEF EXECUTIVE OFFICER, Director 02 Feb 2023, 19:06
/report/000110465923005133-taylor-john-clayton-2023-01-17 Aceragen, Inc. 17 Jan 2023 2 $0 4 Chief Executive Officer, Director 19 Jan 2023, 20:45
/report/000110465922104797-taylor-john-clayton-2022-09-28 IDERA PHARMACEUTICALS, INC. 28 Sep 2022 2 $0 4 Chief Executive Officer, Director 30 Sep 2022, 21:49
/report/000110465922104790-taylor-john-clayton-2022-09-28 IDERA PHARMACEUTICALS, INC. 28 Sep 2022 0 $0 3 Chief Executive Officer, Director 30 Sep 2022, 21:45